20 mg BID of PF-02545920 ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
8	ハンチントン病	1

8. ハンチントン病

臨床試験数 : 242 / 薬物数 : 205 - (DrugBank : 62) / 標的遺伝子数 : 85 - 標的パスウェイ数 : 159

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02342548 (ClinicalTrials.gov)	February 25, 2015	15/1/2015	Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 ...	An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-0 ...	Huntington's Disease	Drug: 20 mg BID of PF-02545920	Pfizer	NULL	Terminated	30 Years	66 Years	All	188	Phase 2	United States;Canada;Germany;Poland;United Kingdom

First Previous1Next Last